Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acquired Immunodeficiency Syndrome
[Developments in the serological diagnosis of malignant diseases]
Adenocarcinoma
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin ?v.
Adenocarcinoma
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Adenocarcinoma
Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Adenocarcinoma
Enzyme activities in human breast tumor cells and sera.
Adenocarcinoma
Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110.
Adenocarcinoma
Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus.
Adenocarcinoma
Increased activity of a beta-galactosyltransferase in tissues of rats bearing prostate and mammary adenocarcinomas.
Adenocarcinoma
Quantitative differences in GlcNAc:beta1-->3 and GlcNAc:beta1-->4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa.
Adenocarcinoma
Treatment and immunodiagnosis of advanced ovarian adenocarcinoma: a preliminary report.
Adenocarcinoma
Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells.
Adenocarcinoma
Tumor markers for ovarian cancer.
Adenocarcinoma
Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
Adenocarcinoma
[Localization and modulation of galactosyltransferase during in vitro proliferation of a human ovarian adenocarcinoma cell line]
Adenocarcinoma of Lung
C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma.
Adenoma
A new method for detecting beta 1,4-galactosyltransferase activity in sera of cancer patients.
Adenoma, Pleomorphic
Cell-surface galactosyltransferase acts as a modulator of rat and human acinar cell proliferation.
Alzheimer Disease
COSMC mutations reduce T-synthase activity in advanced Alzheimer's disease.
Anemia
Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
Anemia
Identification of the full-length coding sequence for human galactosyltransferase (beta-N-acetylglucosaminide: beta 1,4-galactosyltransferase).
Anemia, Dyserythropoietic, Congenital
Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
Anemia, Dyserythropoietic, Congenital
Identification of the full-length coding sequence for human galactosyltransferase (beta-N-acetylglucosaminide: beta 1,4-galactosyltransferase).
Arthritis
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.
Arthritis
Tissue-specific galactosyltransferase abnormalities in an experimental model of rheumatoid arthritis.
Arthritis, Rheumatoid
Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
Arthritis, Rheumatoid
B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.
Arthritis, Rheumatoid
Decreased B-cell galactosyltransferase activity in rheumatoid arthritis.
Arthritis, Rheumatoid
Differential B lymphocyte galactosyltransferase activity in the MRL mouse model of rheumatoid arthritis.
Arthritis, Rheumatoid
Glycosylation and rheumatic disease.
Arthritis, Rheumatoid
Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Polymorphism and expression of the galactosyltransferase-associated protein kinase gene in normal individuals and galactosylation-defective rheumatoid arthritis patients.
Arthritis, Rheumatoid
Reduced B-cell galactosyltransferase activity in rheumatoid arthritis.
Arthritis, Rheumatoid
Serum galactosyltransferase as a marker of disease activity in rheumatoid arthritis.
Arthritis, Rheumatoid
Serum galactosyltransferase isoform changes in rheumatoid arthritis.
Arthritis, Rheumatoid
Tissue-specific galactosyltransferase abnormalities in an experimental model of rheumatoid arthritis.
Autoimmune Diseases
No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients.
Brain Neoplasms
Glycosyltransferase activities in human meningiomas. Preliminary results.
Breast Neoplasms
Alterations in serum glycosyltransferases and 5'-nucleotidase in breast cancer patients.
Breast Neoplasms
Conversion of the amphiphilic galactosyltransferase from human mammary carcinoma cells to an active hydrophilic enzyme form by limited proteolysis.
Breast Neoplasms
Sequential galactosyltransferase and carcinoembryonic antigen levels in advanced breast carcinoma.
Breast Neoplasms
Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma.
Breast Neoplasms
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
Carcinogenesis
Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Carcinogenesis
Quantitative differences in GlcNAc:beta1-->3 and GlcNAc:beta1-->4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa.
Carcinogenesis
The galactosyltransferase activity of hepatic nodules during rat liver carcinogenesis.
Carcinogenesis
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
Carcinoma
Anti-C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer.
Carcinoma
Biochemical and immunologic characterization of galactosyltransferase purified from the ascites of ovarian cancer patients.
Carcinoma
Biological markers and ovarian carcinomas: galactosyltransferase, CA 125, isoenzymes of amylase and alkaline phosphatase.
Carcinoma
Cancer-associated galactosyltransferase acceptor: inhibition of transformed cell and tumor growth.
Carcinoma
Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
Carcinoma
Carbohydrate receptor-mediated gene transfer to human T leukaemic cells.
Carcinoma
Cell-surface galactosyltransferase acts as a modulator of rat and human acinar cell proliferation.
Carcinoma
Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
Carcinoma
Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.
Carcinoma
Comparison of cell-associated and soluble galactosyltransferase isoenzymes from a human bladder transitional cell carcinoma line.
Carcinoma
Conversion of the amphiphilic galactosyltransferase from human mammary carcinoma cells to an active hydrophilic enzyme form by limited proteolysis.
Carcinoma
Elevation of glycoprotein galactosyltransferase activity in human lung cancer related to histological types.
Carcinoma
Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine.
Carcinoma
Expression of galactosyltransferase in prostatic tumors.
Carcinoma
Galactosyltransferase activities in cultured urinary bladder tumor cells.
Carcinoma
Galactosyltransferase activity in metastasizing and nonmetastasizing rat mammary carcinomas and its possible relationship with tumor cell surface antigen shedding.
Carcinoma
Gastrointestinal tumor markers, other than carcinoembryonic antigen, and alpha fetal protein.
Carcinoma
Glycosyltransferase and glycosidase activities in ovarian cancer patients.
Carcinoma
Human intestinal epithelial cells express a novel receptor for IgA.
Carcinoma
In vitro galactosylation of a 110-kDa glycoprotein by an endogenous cell surface galactosyltransferase correlates with the invasiveness of adrenal carcinoma cells.
Carcinoma
Knockdown of Core 1 Beta 1, 3-galactosyltransferase Prolongs Skin Allograft Survival with Induction of Galectin-1 Secretion and Suppression of CD8(+)T Cells : T synthase knockdown effects on galectin-1 and CD8(+)T cells.
Carcinoma
[Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma]
Carcinoma
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level]
Carcinoma, Adenoid Cystic
Cell-surface galactosyltransferase acts as a modulator of rat and human acinar cell proliferation.
Carcinoma, Ehrlich Tumor
Comparison of Ehrlich ascites tumour and mouse liver cells by analytical subcellular fractionation combined with a sensitive computational method for data analysis.
Carcinoma, Embryonal
Embryonal carcinoma cell adhesion: the role of surface galactosyltransferase and its 90K lactosaminoglycan substrate.
Carcinoma, Embryonal
Evidence that galactosyltransferase is a surface receptor for poly(N)-acetyllactosamine glycoconjugates on embryonal carcinoma cells.
Carcinoma, Embryonal
Purification and properties of N-acetylglucosaminide beta 1----4 galactosyltransferase from embryonal carcinoma cells.
Carcinoma, Embryonal
Subcellular localization of N-acetylglucosaminide beta 1----4 galactosyltransferase revealed by immunoelectron microscopy.
Carcinoma, Embryonal
Temporally specific involvement of cell surface beta-1,4 galactosyltransferase during mouse embryo morula compaction.
Carcinoma, Endometrioid
Biological markers and ovarian carcinomas: galactosyltransferase, CA 125, isoenzymes of amylase and alkaline phosphatase.
Carcinoma, Hepatocellular
C1GALT1 Enhances Proliferation of Hepatocellular Carcinoma Cells via Modulating MET Glycosylation and Dimerization.
Carcinoma, Hepatocellular
C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin ?1 glycosylation and activity.
Carcinoma, Hepatocellular
Characterization of galactosyltransferase released from human hepatoma cells.
Carcinoma, Hepatocellular
Characterization of glycosyltransferases in the Golgi complex from rat ascites hepatoma AH-130 cells: a comparison with those from normal liver.
Carcinoma, Hepatocellular
Comparative studies on the uridine-5'-diphosphate-galactose: glycoprotein galactosyltransferase activity in rat liver and Zajdela ascitic hepatoma.
Carcinoma, Hepatocellular
Distribution of glycosyltransferases among Golgi apparatus subfractions from liver and hepatomas of the rat.
Carcinoma, Hepatocellular
Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing.
Carcinoma, Hepatocellular
Galactosyltransferase: multiple forms in serum of normal and hepatoma Mc-29 bearing chickens and from liver and hepatoma microsomal and plasma membrane preparations.
Carcinoma, Hepatocellular
Gangliosides of liver tumors induced by N-2 fluorenylacetamide III. Galactosyl and sialyl transferases in single carcinomas and nodules.
Carcinoma, Hepatocellular
Protein kinase C mu is located at the Golgi compartment.
Carcinoma, Hepatocellular
Serum galactosyltransferase isoenzyme patterns of cancer patients with liver involvement.
Carcinoma, Ovarian Epithelial
Correlation of UDP-galactose glycoprotein:galactosyltransferase levels in the sera with the clinical status of ovarian cancer patients.
Carcinoma, Ovarian Epithelial
Determination of serum galactosyltransferase levels in ovarian cancer patients for the evaluation of the effectiveness of therapeutic programs.
Carcinoma, Squamous Cell
Anti-C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer.
Carcinoma, Squamous Cell
Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
Carcinoma, Squamous Cell
Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through the Golgi apparatus after infection with herpes simplex virus 1.
Carcinoma, Transitional Cell
Comparison of cell-associated and soluble galactosyltransferase isoenzymes from a human bladder transitional cell carcinoma line.
Carcinoma, Transitional Cell
Galactosyltransferase activities in cultured urinary bladder tumor cells.
Cataract
Cataract development in the GalKO mouse.
Cholera
A radioimmune assay of ganglioside GM1 synthase using cholera toxin.
Chondrosarcoma
Solubilization of murine melanoma xylosyltransferase and galactosyltransferase activities and their inactivation by dialdehyde nucleosides.
Colitis
Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture.
Colitis
Elevated miR-124-3p in the aging colon disrupts mucus barrier and increases susceptibility to colitis by targeting T-synthase.
Colitis
Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency.
Colonic Neoplasms
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Colonic Neoplasms
CA19.9 antigen circulating in the serum of colon cancer patients: Where is it from?
Colonic Neoplasms
Colonic cancer cell (HT29) adhesion to laminin is altered by differentiation: adhesion may involve galactosyltransferase.
Colonic Neoplasms
Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale Towards A Personalized Clinical Application.
Colonic Neoplasms
Enzymatic basis for sialyl-Tn expression in human colon cancer cells.
Colonic Neoplasms
Evaluation of galactosyltransferase isoenzyme II in a human colon carcinoma-derived cell line, HCT-8.
Colonic Neoplasms
Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Colonic Neoplasms
Serum galactosyltransferase isoenzymes as markers for solid tumours in humans.
Colonic Neoplasms
Suppression of Core 1 Gal-Transferase Is Associated with Reduction of TF and Reciprocal Increase of Tn, sialyl-Tn and Core 3 Glycans in Human Colon Cancer Cells.
Colorectal Neoplasms
A new method for detecting beta 1,4-galactosyltransferase activity in sera of cancer patients.
Colorectal Neoplasms
Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.
Colorectal Neoplasms
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Colorectal Neoplasms
Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
Colorectal Neoplasms
T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.
Crohn Disease
Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
Crohn Disease
Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency.
Cystic Fibrosis
Properties of microsomal glycoprotein galactosyltransferase of cultured human fibroblasts in relation to cystic fibrosis.
Cystic Fibrosis
Serum factor in cystic fibrosis: correlation with clinical parameters.
Cystic Fibrosis
The levels of galactosyltransferase activity in sera from normal children and patients with cystic fibrosis.
Cysts
N-acetyl-D-glucosamine is present in cysts and trophozoites of Giardia lamblia and serves as receptor for wheatgerm agglutinin.
Cysts
[Applications of tumor markers to the screening of endometrial and ovarian cancers]
Demyelinating Diseases
Upregulation of ?-1,4-Galactosyltransferase I in Rat Spinal Cord with Experimental Autoimmune Encephalomyelitis.
Diabetes Mellitus, Experimental
Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes.
Ehlers-Danlos Syndrome
Broadening the phenotypic spectrum of Beta3GalT6-associated phenotypes.
Ehlers-Danlos Syndrome
Molecular basis for the progeroid variant of Ehlers-Danlos syndrome. Identification and characterization of two mutations in galactosyltransferase I gene.
Endometriosis
[Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]
Esophageal Neoplasms
Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying ?1-integrin glycosylation.
Fatty Liver
Collagen ?(1-O) galactosyltransferase 2 deficiency contributes to lipodystrophy and aggravates NAFLD related to HMW adiponectin in mice.
Fatty Liver
Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.
Glomerulonephritis, IGA
A Novel Fluorescent Assay for T-synthase Activity.
Glomerulonephritis, IGA
Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1 in IgA Nephropathy.
Glomerulonephritis, IGA
Association between C1GALT1 variants and genetic susceptibility to IgA nephropathy in Uygur.
Glomerulonephritis, IGA
C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy.
Glomerulonephritis, IGA
Downregulation of the beta1,3- galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy.
Glomerulonephritis, IGA
Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy.
Glomerulonephritis, IGA
Interaction between GALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy.
Glomerulonephritis, IGA
Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy.
Glomerulonephritis, IGA
Relationship between rs1047763 polymorphism of the C1GALT1 gene and susceptibility to immunoglobulin A nephropathy in Xinjiang Uyghur people.
Glomerulonephritis, IGA
The Association of rs1047763 and rs1008898 of C1GALT1 with IgA Nephropathy Risk: A Global Meta-Analysis.
Glomerulonephritis, IGA
The genetic susceptibility to IgA nephropathy: a novel functional candidate gene for incomplete O-glycosylation of IgA1.
Glomerulonephritis, IGA
Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene.
Glomerulonephritis, IGA
Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy.
Head and Neck Neoplasms
C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
Hemoglobinuria
Differences in the regulation of specific glycosylation in the pathogenesis of paroxysmal nocturnal hemoglobinuria and the Tn-syndrome.
Hemoglobinuria, Paroxysmal
Differences in the regulation of specific glycosylation in the pathogenesis of paroxysmal nocturnal hemoglobinuria and the Tn-syndrome.
Herpes Simplex
Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through the Golgi apparatus after infection with herpes simplex virus 1.
Herpes Simplex
Host cell-induced differences in the O-glycosylation of herpes simplex virus gC-1. II. Demonstration of cell-specific galactosyltransferase essential for formation of O-linked oligosaccharides.
Herpes Zoster
A role for mouse sperm surface galactosyltransferase in sperm binding to the egg zona pellucida.
Herpes Zoster
Binding of caput epididymal mouse sperm to the zona pellucida.
Herpes Zoster
Cell adhesion and fertilization: steps in oocyte transport, sperm-zona pellucida interactions, and sperm-egg fusion.
Herpes Zoster
Cell surface beta 1,4 galactosyltransferase on primary spermatocytes facilitates their initial adhesion to Sertoli cells in vitro.
Herpes Zoster
Further characterization of the mouse sperm surface zona-binding site with galactosyltransferase activity.
Herpes Zoster
Human sperm plasma membranes possess alpha-D-mannosidase activity but no galactosyltransferase activity.
Herpes Zoster
Identification of a deoxyribonucleic acid allelic variant for beta 1-4 galactosyltransferase expression associated with male sperm binding/penetration infertility.
Herpes Zoster
Molecules involved in mammalian sperm-egg interaction.
Herpes Zoster
Plasma membrane association, purification, and partial characterization of mouse sperm beta 1,4-galactosyltransferase.
Herpes Zoster
Receptor function of mouse sperm surface galactosyltransferase during fertilization.
Herpes Zoster
Redistribution of mouse sperm surface galactosyltransferase after the acrosome reaction.
Herpes Zoster
Relationship between two types of mouse sperm surface sites that mediate binding of sperm to the zona pellucida.
Herpes Zoster
Spatial and temporal expression of cell surface galactosyltransferase during mouse spermatogenesis and epididymal maturation.
Herpes Zoster
Stage-specific increase in cell surface galactosyltransferase activity during spermatogenesis in mice bearing t alleles.
Herpes Zoster
The involvement of beta-1,4-Galactosyltransferase and N-Acetylglucosamine residues in fertilization has been lost in the horse.
Herpes Zoster
The receptor function of galactosyltransferase during mammalian fertilization.
Hypersensitivity
Oral feeding with pig peripheral lymphocytes decreases the xenogeneic delayed type hypersensitivity reaction in galactosyltransferase knockout mice.
Infections
Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Infections
Electrophoretic analysis of glycoprotein glycans produced by lepidopteran insect cells infected with an immediate early recombinant baculovirus encoding mammalian beta1,4-galactosyltransferase.
Infections
Elevated glycosyltransferase activities in infected or traumatized hosts: nonspecific response to inflammation.
Infections
The Immunological Regulation Roles of Porcine ?-1, 4 Galactosyltransferase V (B4GALT5) in PRRSV Infection.
Infertility
Identification of a deoxyribonucleic acid allelic variant for beta 1-4 galactosyltransferase expression associated with male sperm binding/penetration infertility.
Infertility, Male
Identification of novel putative causative genes and genetic marker for male sterility in Japanese cedar (Cryptomeria japonica D.Don).
Intracranial Hemorrhages
Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans.
Intracranial Hemorrhages
Targeted disruption of the gene encoding core 1 beta1-3-galactosyltransferase (T-synthase) causes embryonic lethality and defective angiogenesis in mice.
Iron Overload
Chronic liver iron overload in the baboon by ferric nitrilotriacetate. Morphologic and functional changes with special reference to collagen synthesis enzymes.
Joint Instability
Broadening the phenotypic spectrum of Beta3GalT6-associated phenotypes.
Kidney Diseases
Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene.
Leishmaniasis, Visceral
UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.
Leukemia
Elevated thymic and serum galactosyltransferase with low-molecular-weight acceptor activity in murine leukemia.
Leukemia
Glycosyltransferase activities in leukemic cells from patients and human leukemic cell lines.
Leukemia
Release of glycosyltransferase and glycosidase activities from normal and transformed cell lines.
Leukemia, Myeloid
Differentiation-associated changes of glycolipid composition and metabolism in mouse myeloid leukemia cells. Induction of globotriaosylceramide and a galactosyltransferase.
Leukodystrophy, Globoid Cell
Biosynthesis of galactosylsphingosine (psychosine) in the twitcher mouse.
Lipodystrophy
Collagen ?(1-O) galactosyltransferase 2 deficiency contributes to lipodystrophy and aggravates NAFLD related to HMW adiponectin in mice.
Liver Diseases
Abnormal isoelectric focusing patterns of serum galactosyltransferase activity in patients with liver neoplasia.
Liver Diseases
Collagen ?(1-O) galactosyltransferase 2 deficiency contributes to lipodystrophy and aggravates NAFLD related to HMW adiponectin in mice.
Liver Diseases
Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.
Liver Diseases
Glycosyltransferases in human blood. II. Study of serum galactosyltransferase and N-acetylgalactosaminyltransferase in patients with liver diseases.
Lung Neoplasms
C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma.
Lung Neoplasms
Elevation of glycoprotein galactosyltransferase activity in human lung cancer related to histological types.
Lung Neoplasms
Isolation and characterization of cancer-associated galactosyltransferase isoenzyme.
Lupus Erythematosus, Systemic
Glycosphingolipid-associated ?-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus.
Lyme Disease
Functional analysis of a lipid galactosyltransferase synthesizing the major envelope lipid in the Lyme disease spirochete Borrelia burgdorferi.
Lyme Disease
Identification and functional analysis of a galactosyltransferase capable of cholesterol glycolipid formation in the Lyme disease spirochete Borrelia burgdorferi.
Lymphatic Metastasis
A novel mechanism for C1GALT1 in the regulation of gastric cancer progression.
Lymphatic Metastasis
Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
Lymphoma
A comparison of galactosyltransferase activity in mouse ascites lymphoma cells (Ly/Ya), in cultured lymphoma cells, in ascitic fluid and culture medium.
Lymphoma
Galactosyltransferase activities in subcellular fractions of two YC8 lymphoma cell variants : does a relationship exist between antigenic determinants and acceptor sites for galactose?
Lymphoma
Galactosyltransferase and phosphatase activities in physiological fluids from BALB/c mice bearing the YC8 lymphoma.
Malnutrition
Lactose synthesis in the rat, and the effects of litter size and malnutrition.
Melanoma
AGI-134: a fully synthetic ?-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models.
Melanoma
Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection.
Melanoma
Human homolog of Caenorhabditis elegans sqv-3 gene is galactosyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans.
Melanoma
Human melanoma and Chinese hamster ovary cells galactosylate n-alkyl-beta-glucosides using UDP gal:GlcNAc beta 1,4 galactosyltransferase.
Melanoma
Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
Melanoma
Lectin-induced apoptosis of tumour cells.
Melanoma
Metastasis-associated murine melanoma cell surface galactosyltransferase: characterization of enzyme activity and identification of the major surface substrates.
Melanoma
Modulation by all-trans retinoic acid of glycoprotein glycosylation in murine melanoma cells: enhancement of fucosyl- and galactosyltransferase activities.
Melanoma
Solubilization of murine melanoma xylosyltransferase and galactosyltransferase activities and their inactivation by dialdehyde nucleosides.
Meningioma
Glycosyltransferase activities in human meningiomas. Preliminary results.
Myasthenia Gravis
Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
B4GALT1-congenital disorders of glycosylation presents as a non-neurologic glycosylation disorder with hepatointestinal involvement.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
Galactosyltransferase defects in reeler mouse brains.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
New mutations in C1GALT1C1 in individuals with Tn positive phenotype.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
Repressed beta-1,3-galactosyltransferase in the Tn syndrome.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis.
n-acetylgalactosaminide beta-1,3-galactosyltransferase deficiency
T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.
Neoplasm Metastasis
A novel mechanism for C1GALT1 in the regulation of gastric cancer progression.
Neoplasm Metastasis
Anti-C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer.
Neoplasm Metastasis
C1GALT1 Enhances Proliferation of Hepatocellular Carcinoma Cells via Modulating MET Glycosylation and Dimerization.
Neoplasm Metastasis
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin ?v.
Neoplasm Metastasis
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Neoplasm Metastasis
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Neoplasm Metastasis
C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin ?1 glycosylation and activity.
Neoplasm Metastasis
C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma.
Neoplasm Metastasis
Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
Neoplasm Metastasis
Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Neoplasm Metastasis
Expression of galactosyltransferase in prostatic tumors.
Neoplasm Metastasis
Serum galactosyltransferase isoenzyme patterns of cancer patients with liver involvement.
Neoplasm Metastasis
T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.
Neoplasm, Residual
Ovarian cancer and tumor markers: sialic acid, galactosyltransferase and CA-125.
Neoplasms
A comparison of circulating immune complexes, pregnancy associated beta 1-macroglobulin and galactosyltransferase as tumour markers for ovarian cancer.
Neoplasms
A Novel Fluorescent Assay for T-synthase Activity.
Neoplasms
A novel mechanism for C1GALT1 in the regulation of gastric cancer progression.
Neoplasms
A simple and specific assay of glycosyltransferase and glycosidase activities by an enzyme-linked immunosorbent assay method, and its application to assay of galactosyltransferase activity in sera from patients with cancer.
Neoplasms
Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.
Neoplasms
Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
Neoplasms
Abnormal isoelectric focusing patterns of serum galactosyltransferase activity in patients with liver neoplasia.
Neoplasms
Adenovirus-mediated expression of pig alpha(1, 3) galactosyltransferase reconstructs Gal alpha(1, 3) gal epitope on the surface of human tumor cells.
Neoplasms
Alterations in glycosyltransferase activity in human colon cancer.
Neoplasms
Alterations in serum glycosyltransferases and 5'-nucleotidase in breast cancer patients.
Neoplasms
An enzyme immunoassay for galactosyltransferase isoenzyme II, and its clinical application to cancer diagnosis.
Neoplasms
Analysis of the sequences of human beta-1,4-galactosyltransferase cDNA clones.
Neoplasms
Antitumor effect of a liposome-encapsulated ?1,4-galactosyltransferase inhibitor.
Neoplasms
C1GALT1 Enhances Proliferation of Hepatocellular Carcinoma Cells via Modulating MET Glycosylation and Dimerization.
Neoplasms
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin ?v.
Neoplasms
C1GALT1 in health and disease.
Neoplasms
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Neoplasms
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Neoplasms
C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
Neoplasms
C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin ?1 glycosylation and activity.
Neoplasms
C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
Neoplasms
C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma.
Neoplasms
Cancer-associated galactosyltransferase acceptor: inhibition of transformed cell and tumor growth.
Neoplasms
Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
Neoplasms
Cancer-associated isoenzyme of serum galactosyltransferase.
Neoplasms
Cancer-associated serum galactosyltransferase activity. Demonstration in an animal model system.
Neoplasms
Characterization and immunoassay of human tumor-associated galactosyltransferase isoenzyme II.
Neoplasms
Clinical characteristics of a newly developed ovarian tumour marker, galactosyltransferase associated with tumour (GAT).
Neoplasms
Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.
Neoplasms
Comparison of Ehrlich ascites tumour and mouse liver cells by analytical subcellular fractionation combined with a sensitive computational method for data analysis.
Neoplasms
Complementary DNA cloning for galactosyltransferase associated with tumor and determination of antigenic epitopes recognized by specific monoclonal antibodies.
Neoplasms
Convergence: Lactosylceramide-Centric Signaling Pathways Induce Inflammation, Oxidative Stress, and Other Phenotypic Outcomes.
Neoplasms
Correlation of UDP-galactose glycoprotein:galactosyltransferase levels in the sera with the clinical status of ovarian cancer patients.
Neoplasms
Cosmc overexpression enhances malignancies in human colon cancer.
Neoplasms
Critical comments on galactosyltransferase.
Neoplasms
Determination of serum galactosyltransferase levels in ovarian cancer patients for the evaluation of the effectiveness of therapeutic programs.
Neoplasms
Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
Neoplasms
DNA methylation and histone modifications modulate the ?1,3 galactosyltransferase ?3Gal-T5 native promoter in cancer cells.
Neoplasms
Effect of estradiol and prolactin on galactosyltransferase and alpha-lactalbumin activities in rat mammary gland and mammary tumor.
Neoplasms
Elevated thymic and serum galactosyltransferase with low-molecular-weight acceptor activity in murine leukemia.
Neoplasms
Elevation of 4 beta-galactosyltransferase activity for paragloboside synthesis in sera of patients with cancer.
Neoplasms
Eliciting hyperacute xenograft response to treat human cancer: alpha(1,3) galactosyltransferase gene therapy.
Neoplasms
Enzyme activities in human breast tumor cells and sera.
Neoplasms
Evidence for new beta1-3 galactosyltransferase activity involved in biosynthesis of unusual N-glycan harboring T-antigen in Apis mellifera.
Neoplasms
Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine.
Neoplasms
Expression of galactosyltransferase in prostatic tumors.
Neoplasms
Functional assays for the molecular chaperone cosmc.
Neoplasms
Galactosyltransferase activities in human sera of various diseases.
Neoplasms
Galactosyltransferase activity in metastasizing and nonmetastasizing rat mammary carcinomas and its possible relationship with tumor cell surface antigen shedding.
Neoplasms
Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.
Neoplasms
Gangliosides of liver tumors induced by N-2 fluorenylacetamide III. Galactosyl and sialyl transferases in single carcinomas and nodules.
Neoplasms
Glycosyltransferase and glycosidase activities in ovarian cancer patients.
Neoplasms
Glycosyltransferase levels in tumors metastatic to liver and in uninvolved liver tissue.
Neoplasms
Immunoassay of serum galactosyltransferase isoenzyme II in cancer patients and control subjects.
Neoplasms
In vitro and in vivo growth control of transformed lymphoid cells expressing plasma membrane galactosyltransferase.
Neoplasms
Increased activity of a beta-galactosyltransferase in tissues of rats bearing prostate and mammary adenocarcinomas.
Neoplasms
Inhibition of growth of transformed cells and tumors by an endogenous acceptor of galactosyltransferase.
Neoplasms
Inhibition of primary and metastatic tumor growth in mice by cancer-associated galactosyltransferase acceptor.
Neoplasms
Isoenzymatic patterns of human galactosyltransferase from normal and cancer patients.
Neoplasms
Isolation of a Golgi-apparatus-enriched fraction from leukaemic cells.
Neoplasms
Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4-O-Glycan to Cancer Cells.
Neoplasms
MUC1 glycopeptide epitopes predicted by computational glycomics.
Neoplasms
Mucin biosynthesis revisited. The enzymatic transfer of Gal in beta 1,3 linkage to the GalNAc moiety of the core structure R1-GlcNAc beta 1,6GalNAc alpha-O-R2.
Neoplasms
Ovarian cancer and tumor markers: sialic acid, galactosyltransferase and CA-125.
Neoplasms
Overexpression of ?2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.
Neoplasms
Phosphatidylcholine stimulates the activity of UDP-Gal beta 1-4 galactosyltransferase in normal human kidney proximal tumour cells.
Neoplasms
Relevance of ?Gal-?GalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.
Neoplasms
Serum galactosyltransferase as a prognostic marker in patients with solid tumors.
Neoplasms
Serum galactosyltransferase isoenzyme patterns of cancer patients with liver involvement.
Neoplasms
Serum galactosyltransferase isoenzymes as markers for solid tumours in humans.
Neoplasms
Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.
Neoplasms
T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.
Neoplasms
The Cosmc connection to the Tn antigen in cancer.
Neoplasms
The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.
Neoplasms
The Immunological Regulation Roles of Porcine ?-1, 4 Galactosyltransferase V (B4GALT5) in PRRSV Infection.
Neoplasms
Tumour-associated antigens for cystadenocarcinoma of the ovary.
Neoplasms
Udp-galactose: glycoprotein galactosyltransferase activity in a clonal line of rat brain.
Neoplasms
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
Neoplasms
Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
Neoplasms
[A glycoprotein: galactosyltransferase activity in the ascitic fluid and serum of mice with the YC8 tumor]
Neoplasms
[cDNA cloning of galactosyltransferase associated with tumor (GAT)]
Neoplasms
[Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]
Neoplasms
[Clinical usefulness of tumor markers for the diagnosis of ovarian cancer]
Neoplasms
[Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma]
Neoplasms
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level]
Neoplasms
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers]
Nephritis
C1GALT1 polymorphisms are associated with Henoch-Schönlein purpura nephritis.
Non-alcoholic Fatty Liver Disease
Collagen ?(1-O) galactosyltransferase 2 deficiency contributes to lipodystrophy and aggravates NAFLD related to HMW adiponectin in mice.
Ovarian Neoplasms
A comparison of circulating immune complexes, pregnancy associated beta 1-macroglobulin and galactosyltransferase as tumour markers for ovarian cancer.
Ovarian Neoplasms
Alteration in isoenzyme patterns of serum galactosyltransferase activity in ovarian cancer patients: preliminary results.
Ovarian Neoplasms
Analysis of the sequences of human beta-1,4-galactosyltransferase cDNA clones.
Ovarian Neoplasms
Biochemical and immunologic characterization of galactosyltransferase purified from the ascites of ovarian cancer patients.
Ovarian Neoplasms
C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
Ovarian Neoplasms
Characterization of products synthesized by galactosyltransferase purified from the ascites of ovarian cancer patients.
Ovarian Neoplasms
Clinical characteristics of a newly developed ovarian tumour marker, galactosyltransferase associated with tumour (GAT).
Ovarian Neoplasms
Determination of serum galactosyltransferase levels in ovarian cancer patients for the evaluation of the effectiveness of therapeutic programs.
Ovarian Neoplasms
Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.
Ovarian Neoplasms
Murine monoclonal antibodies against galactosyltransferase from the ascites of ovarian cancer patients.
Ovarian Neoplasms
Ovarian cancer and tumor markers: sialic acid, galactosyltransferase and CA-125.
Ovarian Neoplasms
Serum galactosyltransferase activity with three acceptors in ovarian cancer patients.
Ovarian Neoplasms
Tumour-associated antigens for cystadenocarcinoma of the ovary.
Ovarian Neoplasms
Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
Ovarian Neoplasms
[Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]
Ovarian Neoplasms
[Localization and modulation of galactosyltransferase during in vitro proliferation of a human ovarian adenocarcinoma cell line]
Ovarian Neoplasms
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level]
Ovarian Neoplasms
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers]
Pancreatic Neoplasms
Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing.
Pancreatic Neoplasms
Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110.
Pancreatic Neoplasms
Galactosyltransferase isoenzyme II in the detection of pancreatic cancer: comparison with radiologic, endoscopic, and serologic tests.
Pancreatic Neoplasms
Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis.
Pleural Effusion
Galactosyltransferase variant in pleural effusion.
Pleural Effusion
Inhibition of galactosyltransferase activity by cacodylate buffer.
Pleural Effusion
Isolation and characterization of cancer-associated galactosyltransferase isoenzyme.
Pleural Effusion
Monoclonal antibodies to bovine UDP-galactosyltransferase. Characterization, cross-reactivity, and utilization as structural probes.
Pleural Effusion, Malignant
Galactosyltransferase variant in pleural effusion.
Pneumococcal Infections
Elevated glycosyltransferase activities in infected or traumatized hosts: nonspecific response to inflammation.
Progeria
Hutchinson-Gilford progeria: faithful DNA maintenance, inheritance and allelic transcription of beta(1-4) galactosyltransferase.
Prostatic Neoplasms
O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer.
Proteinuria
Loss of mucin-type O-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidney.
Proteinuria
Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3.
Purpura
A study on the association between C1GALT1 polymorphisms and the risk of Henoch-Schönlein purpura in a Chinese population.
Purpura
C1GALT1 polymorphisms are associated with Henoch-Schönlein purpura nephritis.
Renal Insufficiency
Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function.
Retinitis Pigmentosa
[Sialyltransferase and galactosyltransferase of lymphocyte in retinitis pigmentosa]
Rheumatic Diseases
Glycosylation and rheumatic disease.
Rotavirus Infections
Glycan-modifying bacteria-derived soluble factors from Bacteroides thetaiotaomicron and Lactobacillus casei inhibit rotavirus infection in human intestinal cells.
Squamous Cell Carcinoma of Head and Neck
Anti-C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer.
Squamous Cell Carcinoma of Head and Neck
C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
Stomach Neoplasms
A novel mechanism for C1GALT1 in the regulation of gastric cancer progression.
Stomach Neoplasms
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Teratocarcinoma
Identification of a major poly-N-acetyllactosamine-containing cell-surface glycoprotein of mouse teratocarcinoma cells. Appearance on cells induced to primitive endoderm but not parietal endoderm differentiation.
Teratocarcinoma
Secretion of alpha1,3-galactosyltransferase by cultured cells and presence of enzyme in animal sera.
Teratocarcinoma
The use of galactosyltransferase to probe nitrocellulose-immobilized glycoproteins for nonreducing terminal N-acetylglucosamine residues.
Thrombocytopenia
Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene.
Thrombosis
Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
Tuberculosis
Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
Tuberculosis
Inhibition of Escherichia coli glycosyltransferase MurG and Mycobacterium tuberculosis Gal transferase by uridine-linked transition state mimics.
Urinary Bladder Neoplasms
Galactosyltransferase activities in cultured urinary bladder tumor cells.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2.4.1.122 N-acetylgalactosaminide beta-1,3-galactosyltransferase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
